119 related articles for article (PubMed ID: 29103319)
1. In vivo evaluation of electron mediators for the reduction of methemoglobin encapsulated in liposomes using electron energies produced by red blood cell glycolysis.
Ghirmai S; Bülow L; Sakai H
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1364-1372. PubMed ID: 29103319
[TBL] [Abstract][Full Text] [Related]
2. Potential electron mediators to extract electron energies of RBC glycolysis for prolonged in vivo functional lifetime of hemoglobin vesicles.
Kettisen K; Bülow L; Sakai H
Bioconjug Chem; 2015 Apr; 26(4):746-54. PubMed ID: 25734688
[TBL] [Abstract][Full Text] [Related]
3. Red blood cells donate electrons to methylene blue mediated chemical reduction of methemoglobin compartmentalized in liposomes in blood.
Sakai H; Li B; Lim WL; Iga Y
Bioconjug Chem; 2014 Jul; 25(7):1301-10. PubMed ID: 24877769
[TBL] [Abstract][Full Text] [Related]
4. Prolonged functional life span of artificial red cells in blood circulation by repeated methylene blue injections.
Sakai H; Leong C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3123-3128. PubMed ID: 31352837
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin vesicles containing methemoglobin and L-tyrosine to suppress methemoglobin formation in vitro and in vivo.
Atoji T; Aihara M; Sakai H; Tsuchida E; Takeoka S
Bioconjug Chem; 2006; 17(5):1241-5. PubMed ID: 16984134
[TBL] [Abstract][Full Text] [Related]
6. Reduction of methemoglobin via electron transfer from photoreduced flavin: restoration of O2-binding of concentrated hemoglobin solution coencapsulated in phospholipid vesicles.
Sakai H; Masada Y; Onuma H; Takeoka S; Tsuchida E
Bioconjug Chem; 2004; 15(5):1037-45. PubMed ID: 15366957
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury.
Tokuno M; Taguchi K; Yamasaki K; Sakai H; Otagiri M
PLoS One; 2016; 11(10):e0165557. PubMed ID: 27798697
[TBL] [Abstract][Full Text] [Related]
8. Construction of artificial methemoglobin reduction systems in Hb vesicles.
Takeoka S; Ohgushi T; Sakai H; Kose T; Nishide H; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):31-41. PubMed ID: 9083624
[TBL] [Abstract][Full Text] [Related]
9. Translational Research of Hemoglobin Vesicles as a Transfusion Alternative.
Sakai H; Kobayashi N; Kure T; Okuda C
Curr Med Chem; 2022; 29(3):591-606. PubMed ID: 33845721
[TBL] [Abstract][Full Text] [Related]
10. Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content.
Zerez CR; Lachant NA; Tanaka KR
Blood; 1990 Sep; 76(5):1008-14. PubMed ID: 2393709
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model.
Sakai H; Horinouchi H; Tsuchida E; Kobayashi K
Shock; 2009 May; 31(5):507-14. PubMed ID: 18827742
[TBL] [Abstract][Full Text] [Related]
12. Intravascular reduction of methemoglobin in plasma of the rat in vivo.
den Boer PJ; Bleeker WK; Rigter G; Agterberg J; Stekkinger P; Kannegieter LM; de Nijs IM; Bakker JC
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):647-50. PubMed ID: 1391489
[TBL] [Abstract][Full Text] [Related]
13. Methemoglobin formation in hemoglobin vesicles and reduction by encapsulated thiols.
Takeoka S; Sakai H; Kose T; Mano Y; Seino Y; Nishide H; Tsuchida E
Bioconjug Chem; 1997; 8(4):539-44. PubMed ID: 9258453
[TBL] [Abstract][Full Text] [Related]
14. The reduction of methemoglobin in Neo Red Cell.
Ohki N; Kimura T; Ogata Y
Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):477-85. PubMed ID: 9844714
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the binding properties of methemoglobin in red blood cell to cyanide, hydrosulfide, and azide ions using artificial red blood cell.
Suzuki Y; Arakida Y; Sakai H; Enoki Y; Matsumoto K; Taguchi K
Toxicol Appl Pharmacol; 2023 Dec; 481():116752. PubMed ID: 37956930
[TBL] [Abstract][Full Text] [Related]
16. Simulation study of methemoglobin reduction in erythrocytes. Differential contributions of two pathways to tolerance to oxidative stress.
Kinoshita A; Nakayama Y; Kitayama T; Tomita M
FEBS J; 2007 Mar; 274(6):1449-58. PubMed ID: 17489100
[TBL] [Abstract][Full Text] [Related]
17. Development of neo red cells (NRC) with the enzymatic reduction system of methemoglobin.
Ogata Y; Goto H; Kimura T; Fukui H
Artif Cells Blood Substit Immobil Biotechnol; 1997 Jul; 25(4):417-27. PubMed ID: 9242936
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive in vivo monitoring of methemoglobin formation and reduction with broadband diffuse optical spectroscopy.
Lee J; El-Abaddi N; Duke A; Cerussi AE; Brenner M; Tromberg BJ
J Appl Physiol (1985); 2006 Feb; 100(2):615-22. PubMed ID: 16223982
[TBL] [Abstract][Full Text] [Related]
19. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
[TBL] [Abstract][Full Text] [Related]
20. Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempts to prevent the oxidation of hemoglobin.
Faivre B; Menu P; Labrude P; Grandgeorge M; Vigneron C
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):551-8. PubMed ID: 7527721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
